These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
481 related items for PubMed ID: 15719386
1. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG. Liver Transpl; 2005 Mar; 11(3):336-43. PubMed ID: 15719386 [Abstract] [Full Text] [Related]
2. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, Fisher RA, Mihas AA. Hepatology; 2004 Oct; 40(4):802-10. PubMed ID: 15382176 [Abstract] [Full Text] [Related]
4. Evidence-based incorporation of serum sodium concentration into MELD. Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, Benson J, Therneau T, Kremers W, Wiesner R, Kamath P, Klintmalm G. Gastroenterology; 2006 May; 130(6):1652-60. PubMed ID: 16697729 [Abstract] [Full Text] [Related]
5. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis. Lv XH, Liu HB, Wang Y, Wang BY, Song M, Sun MJ. J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416 [Abstract] [Full Text] [Related]
6. Serum sodium and hydration status predict transplant-free survival independent of MELD score in patients with cirrhosis. Mathur S, Gane EJ, McCall JL, Plank LD. J Gastroenterol Hepatol; 2008 Feb; 23(2):239-43. PubMed ID: 17489965 [Abstract] [Full Text] [Related]
7. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality. Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Nojiri K, Aoki T, Sakamoto Y, Hasegawa K, Koike K, Kokudo N. Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024 [Abstract] [Full Text] [Related]
8. Hyponatremia a valuable predictor of early mortality in patients with cirrhosis listed for liver transplantation. Moini M, Hoseini-Asl MK, Taghavi SA, Sagheb MM, Nikeghbalian S, Salahi H, Bahador A, Motazedian M, Jafari P, Malek-Hosseini SA. Clin Transplant; 2011 Mar; 25(4):638-45. PubMed ID: 21077951 [Abstract] [Full Text] [Related]
9. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis. Luca A, Angermayr B, Bertolini G, Koenig F, Vizzini G, Ploner M, Peck-Radosavljevic M, Gridelli B, Bosch J. Liver Transpl; 2007 Aug; 13(8):1174-80. PubMed ID: 17663415 [Abstract] [Full Text] [Related]
10. Predictors of death on the waiting list for liver transplantation characterized by a long waiting time. Gheorghe L, Popescu I, Iacob R, Iacob S, Gheorghe C. Transpl Int; 2005 May; 18(5):572-6. PubMed ID: 15819806 [Abstract] [Full Text] [Related]
11. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list. Ferraz-Neto BH, Hidalgo R, Thomé T, Melo VA, Lobue A, Zurstrassen MP, Moraes JM, Meira-Filho SP, Rezende MB, Fonseca LE, Pandullo FL, Soeiro FS, Afonso RC. Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160 [Abstract] [Full Text] [Related]
12. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study. Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM, ESLD-HIV Working Group Investigators. Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643 [Abstract] [Full Text] [Related]
13. Impact of preoperative serum sodium concentration in living donor liver transplantation. Fukuhara T, Ikegami T, Morita K, Umeda K, Ueda S, Nagata S, Sugimachi K, Gion T, Yoshizumi T, Soejima Y, Taketomi A, Maehara Y. J Gastroenterol Hepatol; 2010 May; 25(5):978-84. PubMed ID: 20546453 [Abstract] [Full Text] [Related]
14. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system? Cuomo O, Perrella A, Arenga G. Transplant Proc; 2008 May; 40(6):1906-9. PubMed ID: 18675085 [Abstract] [Full Text] [Related]
15. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis. Wang YW, Huo TI, Yang YY, Hou MC, Lee PC, Lin HC, Lee FY, Chi CW, Lee SD. J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056 [Abstract] [Full Text] [Related]
16. Model for end-stage liver disease (MELD) and allocation of donor livers. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Kremers W, Lake J, Howard T, Merion RM, Wolfe RA, Krom R, United Network for Organ Sharing Liver Disease Severity Score Committee. Gastroenterology; 2003 Jan; 124(1):91-6. PubMed ID: 12512033 [Abstract] [Full Text] [Related]
17. Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score. Huo TI, Lin HC, Lee FY, Hou MC, Lee PC, Wu JC, Chang FY, Lee SD. Liver Int; 2006 Feb; 26(1):55-61. PubMed ID: 16420510 [Abstract] [Full Text] [Related]
19. Does model for end-stage liver disease (MELD) require modification? Desai HG. J Assoc Physicians India; 2011 Jun; 59():372-3. PubMed ID: 21751591 [Abstract] [Full Text] [Related]
20. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey. Huo TI, Lin HC, Hsia CY, Huang YH, Wu JC, Chiang JH, Chiou YY, Lui WY, Lee PC, Lee SD. Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595 [Abstract] [Full Text] [Related] Page: [Next] [New Search]